Is Ginkgo Bioworks a synthetic biology pioneer or a scam?
This is the big question that investors have been trying to answer since Scorpion Capital earlier this month fired off a scathing 175-page report that sent the company’s newly public shares tumbling and no doubt rattled some of the most high-profile hedge fund managers holding sizable stakes in the company, including Tiger Cub Viking Global Investors, the largest shareholder.
Since
